Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 13
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01738035 | The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease | ||
| NCT03643965 | Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy | ||
| NCT00160082 | Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS) | ||
| NCT03226067 | Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. | ||
| NCT04327089 | Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects | ||
| NCT04541043 | Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) | ||
| NCT05014672 | A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness | ||
| NCT06274489 | A Study to Evaluate Setanaxib in Patients With Alport Syndrome | ||
| NCT00767221 | Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study | ||
| NCT06712407 | Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy | ||
| NCT05323656 | A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) | ||
| NCT02010242 | Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria | ||
| NCT03740217 | Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets |
